ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near London, England, GBR:

TherApeutics in Early ProState Cancer (TAPS02)

trial investigating the use of short term androgen deprivation therapy in the form of apalutamide (Erleada) in men on active surveillance for prostate...

Enrolling
Prostate Cancer
Drug: Apalutamide Oral Tablet [Erleada]
Drug: Placebo

Phase 3

NHS Foundation Trust
NHS Foundation Trust

Cambridge, Cambridgeshire, United Kingdom

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

London, United Kingdom and 92 other locations

A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: ONCT-534

Phase 1, Phase 2

Oncternal Therapeutics

Sutton, Surrey, United Kingdom and 8 other locations

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...

Enrolling
Prostatic Disease
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Drug: Gedatolisib
Drug: Darolutamide

Phase 1, Phase 2

Celcuity

Sutton, United Kingdom and 12 other locations

The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms
Drug: Prednisone
Drug: JNJ-56021927

Phase 1

Aragon Pharmaceuticals

Sutton, United Kingdom and 6 other locations

Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...

Enrolling
Prostate Cancer
Other: No Treatment
Drug: Saruparib (AZD5305)

Phase 1

AstraZeneca
AstraZeneca

Cambridge, United Kingdom and 16 other locations

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110 in Combination with Abiraterone

Phase 1

Arvinas
Arvinas

London, England, United Kingdom and 17 other locations

The study will be conducted in 4 parts and will commence with dose escalation of AMX-500 as a monotherapy (Part 1), followed by monotherapy dose expa...

Enrolling
Hormone-refractory Prostate Cancer
Drug: AMX-500 (SAR446329)

Phase 1, Phase 2

Amunix

London, United Kingdom and 7 other locations

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Enrolling
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

London, United Kingdom and 27 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Guildford, United Kingdom and 131 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems